@ERSpublications Contrast echocardiography is useful for the follow-up of HHT patients with pulmonary arteriovenous malformations http://ow.ly/YNql5Pulmonary arteriovenous malformations (PAVMs) are abnormal vascular structures that connect one or several pulmonary arteries to one or several pulmonary veins without interposition of a capillary bed, resulting in a right-to-left shunt (RLS) [1]. Over 80% of PAVMs are associated with the genetic disease hereditary haemorrhagic telangiectasia (HHT). The vascular malformations predispose patients to severe complications due to paradoxical systemic emboli of thrombotic or septic origin, such as stroke and brain abscess [2][3][4][5]. The treatment of choice for PAVMs is transcatheter embolotherapy, although concerns are emerging regarding the long-term consequences of this procedure, especially in children [6].Because of the risk of severe complications, international guidelines recommend screening patients with HHT for the presence of PAVMs at the time of initial clinical evaluation and also after puberty, after pregnancy, within 5 years preceding a planned pregnancy, and otherwise every 5-10 years [7]. Transthoracic contrast echocardiography (TTCE) is the first-line screening technique for the detection of PAVMs in HHT [7]. In expert hands, it has excellent sensitivity and negative predictive value for the presence of PAVMs in children and adults. Several grading scales are used in different HHT centres to quantify the pulmonary RLS size [6][7][8]. Microbubbles of air in agitated saline may expose patients with RLS to the risk of cerebral air emboli inducing migraine, blurred vision, numbness and paraesthesia, but these symptoms resolve quickly without residual side effects [9,10]. To minimise this risk, many groups perform a chest radiograph prior to TTCE to detect large-size PAVMs, which are likely to carry the highest risk of complications from air bubbles. TTCE is therefore a safe diagnostic tool and its benefits undoubtedly outweigh its potential minor risks.One must bear in mind that TTCE does not detect PAVMs but rather pulmonary RLS. Chest computed tomography (CT) is considered the gold standard diagnostic tool for PAVMs as it enables visualisation of the vascular malformations (except microscopic ones) and provides essential information on their characteristics (shape, location, size of the feeding arteries, size of the aneurismal sac, etc.). Recent studies have reported that, in patients with HHT, the grade of pulmonary RLS on TTCE predicts the size of PAVMs on chest CT and the feasibility of subsequent transcatheter embolotherapy [7]. The absence of, or a small, pulmonary RLS (i.e. a low grade on TTCE) is associated with no risk of neurological complications and with PAVMs too small for embolisation [5,7].